Jennifer E. Cook's most recent trade in BridgeBio Pharma Inc was a trade of 8,425 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BridgeBio Pharma Inc | Jennifer E. Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 8,425 | 8,425 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Jennifer E. Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 6,589 | 13,741 (0%) | 0% | 0 | Common Stock | |
| Denali Therapeutics Inc | Jennifer E. Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 18,111 | 18,111 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Jennifer E. Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 6,037 | 26,075 (0%) | 0% | 0 | Common Stock | |
| Jazz Pharmaceuticals plc | Jennifer E. Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2024 | 3,731 | 10,619 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Jennifer E. Cook | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 111.35 per share. | 02 Aug 2024 | 1,484 | 9,135 (0%) | 0% | 111.3 | 165,243 | Ordinary Shares |
| BridgeBio Pharma Inc | Jennifer E. Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 26,014 | 26,014 | - | - | Stock Option (Right to Buy) | |
| Denali Therapeutics Inc | Jennifer E. Cook | Director | Sale of securities on an exchange or to another person at price $ 21.73 per share. | 06 Jun 2024 | 1,458 | 20,038 (0%) | 0% | 21.7 | 31,682 | Common Stock |
| Denali Therapeutics Inc | Jennifer E. Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 17,901 | 17,901 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Jennifer E. Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 5,967 | 21,496 (0%) | 0% | 0 | Common Stock | |
| Jazz Pharmaceuticals plc | Cook Jennifer E. | Director | Sale of securities on an exchange or to another person at price $ 119.27 per share. | 04 Dec 2023 | 417 | 6,888 (0%) | 0% | 119.3 | 49,736 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Jennifer E. Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2023 | 3,075 | 8,546 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Jennifer E. Cook | Director | Sale of securities on an exchange or to another person at price $ 138.16 per share. | 11 Aug 2023 | 1,241 | 7,305 (0%) | 0% | 138.2 | 171,454 | Ordinary Shares |
| BridgeBio Pharma Inc | Jennifer E. Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 51,501 | 51,501 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Jennifer E. Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 12,649 | 12,649 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Jennifer E. Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 4,216 | 15,529 (0%) | 0% | 0 | Common Stock | |
| BridgeBio Pharma Inc | Jennifer Cook E. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2021 | 3,576 | 7,152 (0%) | 0% | - | Common Stock | |
| BridgeBio Pharma Inc | Jennifer Cook E. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2021 | 3,576 | 0 | - | - | Restricted Stock Units | |
| BridgeBio Pharma Inc | Jennifer Cook E. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 38,895 | 38,895 | - | - | Stock Option (right to buy) |